Cell-specific and Hormone-regulated Expression of Gonadotropin-regulated Testicular RNA Helicase Gene (GRTH/Ddx25) Resulting from Alternative Utilization of Translation Initiation Codons in the Rat Testis*

Yi Sheng, Chon-Hwa Tsai-Morris and Maria L. Dufau {ddagger}

From the Section on Molecular Endocrinology, Endocrinology and Reproduction Research Branch, NICHD, National Institutes of Health, Bethesda, Maryland 20892-4510

Received for publication, March 7, 2003 , and in revised form, April 21, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Gonadotropin-regulated testicular RNA helicase (GRTH) is a novel DEAD-box protein with ATPase and RNA helicase activities. GRTH gene transcription is stimulated by human chorionic gonadotropin (hCG) via cyclic AMP-induced androgen formation in testicular Leydig cells. In this study, immunocytochemical and Western analyses identified GRTH as a developmentally regulated protein in Leydig cells and in germ cells (pachytene spermatocytes and round spermatids) of the rat testis. Three ATGs with the potential for generation of multiple protein species were identified. Germ cells primarily utilized the 1st ATG codon (+1) and contained major proteins of 61/56 kDa, whereas Leydig cells utilized preferentially the 2nd ATG codon (+ 343) with expression of 48/43 kDa species. A 3rd ATG was weakly utilized and yielded a 33-kDa protein only in germ cells. The increase in GRTH 43-kDa protein in Leydig cells caused by hCG treatment was prevented by the androgen receptor antagonist, flutamide. In round spermatids, hCG caused a significant decrease of 61 kDa species and an induction 48/43 kDa species, whereas no changes were observed in pachytene spermatocytes. Reversal of this hormone-induced switch of expression by flutamide indicated a role of androgen in utilization of the 2nd ATG. These studies have demonstrated a cell-specific and hormone-dependent alternative usage of ATG codons in the testis. They have also revealed that the androgen-dependent transcription of GRTH expression in Leydig cells is accompanied by a marked increase of 43-kDa species. The findings indicate that expression of GRTH proteins is regulated by gonadotropin/androgen at the translational level.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
RNA helicases are ribonucleic acid-binding proteins that regulate RNA structure, possess ATPase activity, and unwind double-stranded RNA in an ATP-dependent manner (1, 2). A large number of RNA helicases have been identified, and these were classified into superfamilies based on specific amino acid sequences in the conserved motifs common to all family members. Among these proteins, DEAD-box proteins were grouped in a family of RNA helicases; that is, the DEAD-box family (Asp-Glu-Ala-Asp), whose members exert regulatory roles in various aspects of RNA metabolism including translation, nuclear transcription, pre-mRNA splicing, mRNA export, and ribosome biogenesis (1, 2). In addition, some members of the DEAD-box family participate in regulatory events during organ maturation and cellular differentiation (1, 2).

The gonadotropin-regulated testicular RNA helicase (GRTH/Ddx25),1 cloned from the rat Leydig cell, mouse and human testis cDNA libraries, is a novel member of the DEAD-box protein family of RNA helicases and is the first member found to be regulated by a hormone (3). Purified recombinant GST-GRTH displayed ATPase and ATP-dependent bi-directional RNA helicase activities. It also increased in vitro translation of luciferase RNA templates (3). Northern analysis indicated that this helicase is highly expressed in rat, mouse, and human testes and is weakly expressed in the pituitary and hypothalamus. In vivo/in vitro studies demonstrated that GRTH is transcriptionally up-regulated by human chorionic gonadotropin at doses that cause down-regulation of luteinizing hormone/human chorionic gonadotropin (hCG) receptors, steroidogenic enzymes, and androgen formation (4). Furthermore, in vitro studies revealed that induction of GRTH mRNA by hCG is mediated via second messenger and androgen in Leydig cells. Inhibition of androgen production by inhibitors of steroidogenic enzymes or blockade of androgen action by a receptor antagonist abrogated the stimulation of GRTH mRNA by gonadotropin or cAMP. In situ hybridization analysis demonstrated that GRTH is predominantly expressed in the testis in both somatic Leydig cells and meiotic spermatocytes and haploid germinal cells of the seminiferous epithelium and is developmentally regulated. In the present study, we identified GRTH protein species, evaluated their protein levels, and studied their cellular distribution within the testicular compartments and their hormonal regulation in the adult rats testis. The regulation of this enzyme by gonadotropin and androgen and its stage-specific localization in germ cells indicate that GRTH could participate in the regulation of androgen-dependent steroidogenesis and spermatogenesis.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Animal Treatment—Adult and 21-day old male rats (Charles River Laboratories Inc., Wilmington, MA) were housed in pathogen-free, temperature- and light-controlled conditions (20 °C; alternating light-dark cycle with 14 h of light and 10 h of darkness). All animal studies were approved by the National Institute of Child Health and Human Development animal and care and use committee (protocol 00-044). Adult male rats were given subcutaneous injections of 2.5 µg of hCG (Pregnyl, Organon pharmaceuticals, The Netherlands) in Dulbecco's phosphate-buffered saline. For in vivo studies to explore gonadotropin-mediated androgen effect on GRTH expression in Leydig cells, adult male rats were injected with the androgen receptor antagonist flutamide (2-methyl-N-[4-nitro-3-(trifluoromethyl)-phenyl]propanamide, Sigma) (5 mg, 2 times a day for 3 days) followed by 2 injections of flutamide with a 12-h interval and a single subcutaneous 2.5-µg dose of hCG 24 h before sacrifice. Animals were killed by asphyxiation with CO2 and decapitated 24 h after hCG or vehicle (controls) treatment unless otherwise indicated. Leydig cells (interstitium) and germinal cells (seminiferous tubule) were prepared from decapsulated testes and further purified for protein extraction, to be analyzed by Western blots.

Testicular Leydig and Germ Cells Preparation—Leydig cells were prepared by collagenase dispersion and purified by centrifugal elutriation (5). After collagenase dispersion, seminiferous tubules were minced and incubated in Medium 199 containing 0.1% bovine serum albumin, 0.1% trypsin (Sigma), and 17 µg/ml DNase (Sigma) for 30 min in a rotary water bath (80 rpm, 35° C). After the addition of soybean 0.04% trypsin inhibitor, the sample was filtered through a 300-, 90-, 40-µm mesh screen, and glass wool and cells were pelleted and resuspended in elutriation buffer containing 2 µg/ml DNase. The relevant types of germ cells were subsequently separated and purified by centrifugal elutriation using Beckman Avanti 21B centrifuge with elutriator rotor model J 5.0 as described previously (6). The first 2 fractions (1 and 2) were collected with flow rates of 31.5 and 41.4 ml/min at 3000 rpm, and 2 additional fractions (3 and 4) were obtained with flow rates of 23.2 and 40 ml/min at 2000 rpm. Cells were identified on air-dried smears, fixed in Bouin's fixative, and stained with hematoxylin and periodic acid-Schiff. Fractions 2 and 4 containing round spermatids and pachytene spermatocytes at a purity of 84 and 86%, respectively, were used for Western blot analyses.

Western Blot and Immunohistochemistry Analysis—A polyclonal antibody was raised in rabbits against a GRTH peptide (amino acids 465–477) and purified by protein A-Sepharose (Amersham Biosciences). Protein extracts from testicular Leydig, germ cells, and various tissues including adrenal, ovary, pancreas, brain, and pituitary were assessed by Western blot analysis using the purified GRTH antibody (1/400 dilution, 1 µg of IgG/µl). The specificity of the antibody-GRTH interaction was evaluated in the presence of 60 µM GRTH peptide 465–477. Immunosignals were detected by a super-signal chemiluminescent system (Pierce). GRTH values were normalized by the corresponding {beta}-actin signals. For immunochemistry analysis, testes from adult rats were fixed in 4% paraformaldehyde and embedded in paraffin. Serial sections were incubated with GRTH antiserum at a 1/500 dilution (1 µg IgG/µl) and developed with a peroxidase-labeled avidin biotin detection system. Sections of seminiferous tubules were staged according to the method of Leblond and Clermont (7). Quantitation of relative immunostaining intensity was performed by three independent observers using scores 0–5 assigned for the signal varying from absent, weak, medium, high, to maximum by vision inspection. At least 50 pachytene spermatocytes and round spermatids per stage in 10 different seminiferous tubules were evaluated by two observers. Maximum intensity observed at the stage IX pachytene spermatocyte was defined as score 5.

Overexpression of GRTH-GFP and GRTH-PBK Protein in COS-1 Cells—The full length of the GRTH cDNA-coding region including the first ATG codon (newly identified) or from the second ATG codon (first ATG in our previous report (3)) were subcloned into the pEGFP-N2 (GRTH-GFP) or pBK (GRTH-PBK) (2 µg) and transfected into COS-1 cells with LipofectAMINE Plus (Invitrogen). After 36 h, cells were harvested for Western blot analyses by using a GFP monoclonal antibody (Clontech, Palo Alto, CA) or purified GRTH antibody.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Western Analysis of GRTH Gene Expression—In the process of cloning and analyzing the promoter domain of GRTH gene, we encountered a single nucleotide (G) deletion at nt–272 bp in our previous reported cDNA sequence (3). This was verified at the cDNA level by sequencing clones isolated from a rat testis library. With this single-base pair addition, the GRTH cDNA contains 357 additional base pair and an ATG codon (+1) 5' in-frame to the original cDNA ATG codon (earlier defined as +1 bp, now revised as +343 bp). This sequence of 1630 bp contains an open reading frame encoding 483 amino acids, with the additional 114 amino acids resulting from 5' sequences of our earlier reported clone (Fig. 1B). A motif search by the GCG program of the 114-amino acid N-terminal sequence identified a consensus leucine zipper pattern (LX6LX6LX6L) with the last leucine missing (amino acid 18–32) in rat, mouse, and human species. A data base search revealed high amino acid sequence homology of GRTH in rat, mouse, and human species (93–98%). Four regions (amino acids 65–71, 82–86, 91–97, and 99–105) within the N-terminal sequences are conserved between GRTH of rat, mouse, and human and DBP5 of mouse and human (8, 9). Furthermore, our recent studies demonstrated that the TATA-less GRTH gene contains multiple transcriptional start sites located within 80 bp 5' to the first ATG codon (+1).2



View larger version (26K):
[in this window]
[in a new window]
 
FIG. 1.
A, Western analysis of overexpressed GRTH protein in COS-1 cells and endogenous levels of GRTH protein in the adult rat testis. Shown is Western analysis of GRTH-GFP fusion protein (constructs A and B), GFP control, or GRTH-PBK (construct C) overexpressed in COS-1 cells. A schematic of the constructs used in the overexpressed study is indicated at the bottom of the panel. Arrows indicate the positions of initiation ATG nucleotides and amino acids. Protein bands from extracts of transfected cells were detected using a GFP monoclonal antibody (Ab)(left-most panel) or GRTH-specific polyclonal antiserum (second panel). Endogenous GRTH protein bands from whole testis (third panel), purified Leydig cells (LC), and germ cells (RS, round spermatids; P, pachytene spermatocytes) (fourth panel) detected with GRTH polyclonal antibody are shown. Complete inhibition of the antibody-GRTH interaction was observed in the presence of the GRTH peptide (right-most panel). B, sequences of extended 5' open-reading-frame nucleotides (342 bp) of rat GRTH cDNA and deduced amino acids (114 amino acids). The complete open reading frame of GRTH contains 483 amino acids. Potential translation initiation codons are indicated in nucleotides (atg) or methionine (M).

 

To further analyze the expression of this full-length cDNA we performed Western analysis using either specific GRTH antiserum or GFP monoclonal antibody for GRTH-GFP fusion protein overexpressed in COS-1 cells. Western blot analyses using a GFP monoclonal antibody showed expression of GRTH-GFP fusion proteins with construct A, which contains both first and second ATG (new clone), and construct B, our previous clone with only the 2nd ATG (Fig. 1A, left-most panel, lanes A and B). Expression of construct A revealed a predominant 83-kDa band (56-kDa GRTH, 27-kDa GFP) and a weak 70-kDa protein band (43-kDa GRTH, 27-kDa GFP) and that of construct B, a 70-kDa band. This indicated utilization of both ATGs in the translation process. A 27-kDa GFP band was detected in cells transfected with the GFP construct without the GRTH insert (Fig. 1A, left-most panel, lane GFP). An additional 88-kDa species (61-kDa GRTH, 27-kDa GFP) was also observed. All protein species corresponding to the overexpressed GRTH-GFP fusion protein were also detected with a specific GRTH polyclonal antibody (Fig. 1A, second panel, lanes A and B). In addition to the predominant band of 88/83 kDa, a second less prominent protein band of 70 kDa was detectable by the GRTH antibody from the expression of the full-length GRTH-GFP fusion construct A (Fig. 1A, second panel, lane A). This corresponded to the deduced protein size derived from the amino acid sequence reported in our early studies (3) (construct B, lane B), suggesting that the 2nd ATG in the coding region can also function in the translation process.

Also, the expressed protein species resulting from transfecting the construct containing full-length GRTH in PBK vector (construct C) were evaluated. We observed 61/56-kDa (predominant) and 43-kDa (minor) bands of size comparable with that calculated from the expressed GRTH-GFP construct (A) that corresponded to usage of the 1st and 2nd ATG codons, respectively (Fig. 1A, second panel, lane C).

These findings demonstrate that newly identified ATG is the major translation initiation codon in overexpression studies in COS1 cells. However, the 2nd ATG codon appears to function in a cell-specific manner in Leydig cells (Fig. 1A, fourth panel), and it may also play a significant role under hormonal stimulation (see Fig. 6). There are specific endogenous 56 – 61-kDa protein complexes detected in the whole testis (third panel) and purified adult rat testicular germ cells (round spermatids and pachytene spermatocytes) (Fig. 1A, fourth panel, lanes RS and P), whereas the 43-kDa protein is the major protein species in Leydig cells. Other minor protein bands of 48 and 56 kDa are also expressed in Leydig cells (Fig. 1A, fourth panel, lane LC). An additional minor protein band 33 kDa was also noted in germ cells (Fig. 1A, fourth panel, lanes RS and P). The later may result from utilization of ATG codons at +568 or +598. The specificity of the endogenous GRTH protein bands was confirmed by inhibition of the antibody-GRTH complex by the peptide used to prepare the antibody (Fig. 1A, right-most panel).



View larger version (59K):
[in this window]
[in a new window]
 
FIG. 6.
Western analysis of GRTH expression in germ cells of adult rats. Adult rats were treated with flutamide (Flut.) or/and hCG as indicated under "Experimental Procedures." Protein samples from purified germ cells of adult rats (RS, round spermatids; P., pachytene spermatocytes) were analyzed by Western blot. C, control; LC, Leydig cells.

 

Developmental studies revealed that endogenous testicular GRTH protein was expressed predominantly as the 61/56-kDa form observed in the testes of pubertal and adult animals but was not present in immature animals (Fig. 2A), whereas a weak 43-kDa protein was expressed in the adult testis. This is reasonable because Leydig cells, which are the major source of the 43-kDa species, represent about 4% of the total testis cell volume (10). GRTH was not observed in other organs examined including adrenal, ovary, heart, hypothalamus, or pituitary (Fig. 2B).



View larger version (28K):
[in this window]
[in a new window]
 
FIG. 2.
Developmental analysis and tissue distribution of GRTH protein in the rat. Western analysis of GRTH expression using purified GRTH polyclonal antisera in the testes of different ages (1–8 weeks old) (A) and various tissues from adult male rat (B). LC, Leydig cells; wk, week.

 

Immunocytochemical Analysis of GRTH in Adult Rat Testis—Immunohistochemistry studies showed that GRTH immunoreactive protein was predominantly present in the interstitial cells of the adult rat testis and weakly expressed in the seminiferous tubules (Fig. 3A, a and b). Subsequent studies revealed that the intensity of positively stained germ cells varied during the spermatogenic cycle (see Figs. 3B and 4).



View larger version (121K):
[in this window]
[in a new window]
 
FIG. 3.
A, immunohistochemical localization of GRTH in interstitial Leydig cells of adult testes. a, immunostaining signals are significantly stronger in interstitial Leydig cells (LC) compared with seminiferous tubules (ST). b, purified rabbit IgG was used as the negative control. B, immunohistochemical localization of GRTH in the seminiferous tubule of adult testes. Immunoreactive GRTH signals at the different identified stages of the spermatogenic cycle (I-XIV) were determined using previously established criteria (7). Shown are pachytene spermatocyte (P), round spermatids (RS), elongating/elongated spermatids (ES), diplotene (Di), leptotene (L), and zygotene (Z) spermatocytes and Sertoli cells (S), and residual bodies (RB). Negative control using rabbit IgG (VIIIc, IXc, and XIVc). Sm, spermatocytes in the metaphase of meiosis.

 


View larger version (50K):
[in this window]
[in a new window]
 
FIG. 4.
A, changes of the GRTH-immunostaining signals in pachytene spermatocytes and round spermatids during the spermatogenic cycle of the adult rat testes. Results assessed at different stages of seminiferous tubules by scoring as described under "Experimental Procedures" are presented as arbitrary levels. Highest signals were observed at stages VIII-IX of pachytene spermatocytes and stage IX of elongating spermatids. B, schematic representation of the spermatogenic cycle of the adult rat. The box area indicates the type of germ cells at the different stages to be correlated with GRTH protein expression revealed by immunostaining. The intensity of GRTH expression was arbitrarily scored. Maximal intensity observed at stage IX of pachytene spermatocyte was defined as 5.

 

To determine the cellular expression patterns of GRTH protein in the seminiferous tubules during germ cells development, we performed a detailed analysis of immunoreactive staining present in different types of germ cells during the spermatogenic cycle of the adult rat testis (Fig. 3B). Both pachytene spermatocytes and round spermatids expressed GRTH protein, and the intensity of staining in the individual cell types varied at different stages of the spermatogenic cycle. GRTH immunoreactive protein staining was significantly higher in round spermatids when compared with pachytene spermatocytes only at early stages (I-III). GRTH levels in round spermatids reached peak levels at stages VIII and IX and were diminished in late stages of elongating spermatids. In pachytene spermatocytes, signals were minimally detectable in stage I and gradually increasing at stages II through IX. The strongest immunoreactive signals were observed in stage VIII and IX, where levels were significantly higher compared with round spermatids. GRTH immunoreactivity in pachytene spermatocytes was gradually decreased from stages X through stage XIII. It was noted that immunoreactive signals were prominent in stage XIV of spermatocytes when cells entered the metaphase of meiotic division. GRTH was not expressed in Sertoli cells or other types of germ cells.

Analysis of the intensity of GRTH immunoreactive signals at different stages of round spermatids and pachytene spermatocytes during the spermatogenic cycle and the corresponding pattern of individual cell types are shown in Fig. 4, A and B. The specific cell and stages of GRTH protein expression during germ cells development suggests that GRTH may play an important role in spermatogenesis.

Gonadotropin Up-regulation of GRTH Expression in Adult Rat Testes—The GRTH protein levels were significantly increased in adult rat Leydig cells (43 kDa) at 12 h after gonadotropin treatment of adult rats, further increased at 24 h, and returned to near control level at 96 h (Fig. 5A). The weaker 48- and 56-kDa species were unchanged at 12 h but were not detectable at 24 h and were again observed 96 h after treatment (Fig. 5B). The increase of the 43-kDa GRTH species in Leydig cells caused by gonadotropin was prevented by flutamide treatment (Fig. 5C). Flutamide treatment per se also reduced GRTH protein to 56% that of controls (p < 0.01). These findings indicated that GRTH protein expression is up-regulated by the action of androgen induced by gonadotropin stimulation in the Leydig cells.



View larger version (45K):
[in this window]
[in a new window]
 
FIG. 5.
A, time course studies of GRTH protein level regulated by hCG in rat Leydig cells. Western blot analysis of GRTH proteins from Leydig cells of adult male rats injected with 2.5 µg of hCG or vehicle (control) 24 h before sacrifice. The major 43-kDa band revealed by autoradiography (upper) was quantified by densitometry (lower). Counts were normalized by {beta}-actin and presented as percent mean ± S.E. relative to controls. B, Western blot showing changes induced by hCG in all protein species in Leydig cells. In addition to major increases of the predominant 43-kDa band induced by hormone treatment, note the disappearance of the minor bands of 48 and 56 kDa at 24 h and return at 96 h. C, in vivo study of hormone effects on GRTH protein level in Leydig cells. Adult rats were treated with flutamide or/and hCG as indicated under "Experimental Procedures." Protein samples from Leydig cells of adult rats were analyzed by Western blot. Results were recorded by autoradiography (upper) and quantified by densitometry (lower). Counts were normalized by {beta}-actin and presented as percent mean ± S.E. relative to controls.

 

In germ cells the GRTH protein (61/56 kDa) were markedly affected by gonadotropin stimulation in a cell-specific manner (Fig. 6). Although there were no changes observed in pachytene spermatocytes, gonadotropin treatment significantly altered the pattern of protein expression in round spermatids. In these cells the 61-kDa species was significantly decreased to barely detectable levels, whereas only minor reduction in the 56-kDa species were observed. Most notably was the marked induction of the 48/43-kDa species that were undetectable in round spermatids of control animals. Moreover, treatment with flutamide prevented the induction of these species by hCG in the round spermatids. This indicated alternative utilization of GRTH translation initiation codon governed by direct or indirect action of androgen in these cells.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
This study has identified GRTH cDNA clones that contain an in-frame ATG codon 5' upstream to the translation initiation codon present in the cDNA previously cloned in our laboratory. This additional codon extends the open reading frame of GRTH by 114 amino acids. Both ATG codons are actively translated in the adult rat testis, and the GRTH protein is expressed in both Leydig cells and germinal cells. Also, there is a cell-specific and hormone-dependent usage of ATG codons in the testis. Our findings revealed up-regulation of GRTH in the Leydig cells and a switch of GRTH protein species expressed in round spermatids induced by gonadotropin treatment and a direct or indirect involvement of androgen in this regulation. These results support the notion that androgen exerts regulatory function in GRTH gene expression.

The primary antibody used in this study is a rabbit polyclonal antibody raised against a synthetic peptide corresponding to the unique C-terminal amino acid sequence (amino acids 465–477), with no similarity to any other member of RNA helicase gene family or known proteins. Western blot analyses of transiently transfected COS-1 cells with various constructs (Fig. 1) confirmed the antibody specificity since both GRTH and GFP antibodies revealed major 88/83-kDa species and a minor 70-kDa protein band from expression of GRTH-GFP fusion construct A. Moreover, the 70-kDa species was detected from expression of the 5'-truncated GRTH-GFP, construct B. In cells transfected with construct C, both the 61/56- and 43-kDa species were present. The observed sizes of the endogenous proteins (61/56- and 43-kDa species) were consistent with those derived from the deduced amino acid sequences and the expressed GRTH-GFP fusion proteins corrected for the GFP contribution. The ~5-kDa difference observed in the 61 versus 56-kDa and 48 versus 43-kDa species may result from post-translational modification (i.e. N-glycosylation at amino acid site 426 or 472). The difference of the 61/56- and 48/43-kDa species can be accounted for by codon usage at ATG +1 and +343 nt, respectively. The intensity of the 61-kDa species is stronger than the 56-kDa species in the testis and round spermatids, whereas the pachytene spermatocytes do not the contain 56-kDa species. In Leydig cells, the 43-kDa protein is the dominant species. The mechanism involved in the formation of these various GRTH protein species and the significance of their respective function in specific cell types remain to be resolved. GRTH was present in testis and not detected in other tissues examined, including ovary, hypothalamus, and pituitary. The lack of detectable protein expression in these tissues is of interest since our previous study demonstrated mRNA expression at these sites (3) and indicates a lack of translatability or very low levels of the protein, undetectable by the method employed.

Production of multiple protein isoforms could result from transcriptional and/or translational mechanism. Different promoter usage, alternate mRNA splicing, utilization of alternative translation initiation codon, and proteolytic cleavage could generate protein diversity and ultimately fulfill unique biological functions. Because GRTH mRNA is a single transcript of 1.6 kilobases, one of the mechanisms for the differential expression of GRTH protein species in the testis is the alternative initiation of translation from different ATG codons. Initiation of translation at alternative ATG codons in a single transcript has been documented for a number of genes including intron-less members of C/EBP family, C/EBP{beta} (11), and C/EBP{alpha} (12) and intron-containing Egr3 gene and eukaryotic translation initiation factor 4GI (13, 14). In the case of the GRTH gene, the usage of alternative ATG codons is supported by findings from overexpression studies of engineered constructs containing different GRTH translational initiation codons. It is also indicated by the size of the specific GRTH protein species endogenously expressed in the testis, which corresponded to the proposed ATG initiation codons (Fig. 1). The overexpression studies indicated that both ATG codons at +1 and +343 nt of GRTH actively initiated the synthesis of different protein species. Testicular germ cells preferentially utilize the +1 ATG codon, whereas Leydig cells use the 2nd ATG codon at nt +343 in the translation process. In addition, there is a 3rd functional ATG codon at nt 568 or 598 that is utilized in germ cells exclusively yielding a 33-kDa species. All the sequences surrounding these different initiation codons contain consensus Kozak sequences (GCC(A/G)CCATGG) with 2–4 nt mismatches 5' to ATG (Fig. 1). Although the 1st ATG codon at +1 nt position appears to better match the consensus Kozak sequence, our study indicated that all the proposed ATG codons are functional depending on the cell type.

Although proteolytic cleavage could also be an alternative mechanism for generation of different protein isoforms, we believe this is unlikely in the case of GRTH gene products. The rationale is based on the fact that ATG codons are not only utilized in a cell-specific manner but also appear to be hormonally sensitive in a specific type of germ cells (round spermatids). The switch between 1st and 2nd ATG usage in round spermatids is dependent on the gonadotropin stimulation and androgen production. In the presence of hormone, 48/43-kDa protein species were generated presumably using the translation initiation codon located at nucleotide 343. The possibility of generating identical 48/43-kDa protein species as the Leydig cells through a proteolytic process induced by gonadotropin would be very low. It is important to note that the Leydig cell is tonically regulated by gonadotropin, a hormone and that promotes androgen (testosterone) formation in these cells. Autocrine actions of testosterone in Leydig cells and paracrine actions at tubule sites (round spermatids) exert increases in GRTH and promote the utilization of the 2nd ATG codon in both cell types. The usage of an alternative ATG codon by a stimulant was also reported for isoform formation of the murine interleukin-12 gene during lipopolysaccharide stimulation (15).

The action of androgen on GRTH protein expression in germ cells appears to be cell-specific, although germinal cells do not exhibit either gonadotropin or androgen binding activity (16, 17). In contrast to the up-regulation of GRTH gene expression caused by hCG-induced androgen action in the Leydig cells, GRTH protein levels in purified pachytene spermatocytes were not affected by hormonal stimulation. However, the 48/43-kDa protein species were induced by gonadotropin treatment in round spermatids, whereas the 61-kDa protein species was markedly diminished in this cell type. We propose that a specific androgen response factor(s) that is present in both Leydig cell and round spermatids but not in pachytene spermatocytes promotes utilization of the 2nd ATG codon of GRTH mRNA for the synthesis of 48/43-kDa GRTH protein.

The up-regulation of GRTH expression by gonadotropin/androgen Leydig results from transcriptional regulation (3), and this also applicable to the GRTH induction observed during development in the various cell types. In preliminary studies we have determined that the GRTH gene, which lacks consensus androgen/glucocorticoid-responsive element, is not modulated by androgen in COS-1 cells co-transfected with androgen receptor and GRTH promoter/5'-flanking construct.3 This indicated indirect cell-specific actions of androgen on GRTH transcription in the testis. On the other hand, the prevalence of the 48/43-kDa species in Leydig cells and the hormonal switch of expressed species in round spermatids is reflective of alternative promoter usage. Thus, this indicates that the 48/43-kDa protein is an androgen-responsive protein that may participate in both metabolic function of the Leydig cells and spermatogenesis.

Studies on the distribution of the GRTH immunoreactive protein in the seminiferous epithelium of the adult rat testis have clearly demonstrated that GRTH expression is cell- and stage-specific during germ cell development. Immunocytochemical analysis showed the presence of high levels of GRTH in pachytene spermatocytes and haploid spermatids at stages VIII to IX. High levels of GRTH immunostaining was also observed in the metaphase of primary and secondary spermatocytes at stage XIV when chromosomes are condensed. The cell- and stage-specific GRTH expression in the germ cell maturation process suggests that GRTH may act either directly or indirectly on germ cells to regulate spermatogenesis.

Several candidate genes for the regulation of spermatogenesis have been reported. Within the DEAD-box protein helicase family, Mvh (18), a mouse homolog of the Drosophila maternal gene Vasa that is required for the completion of oogenesis (19), is expressed in male premeiotic germ cells and appears to be associated with the meiotic process. Moreover, homozygous knockout Mvh mice produced no sperm in the testis due to the failure of premeiotic cells to complete meiosis (18). Two other evolutionary DEAD-box RNA helicase genes distantly related to GRTH, mouse PL10 (20) and P68 (21), displayed testis-selective mRNA expression restricted to late pachytene spermatocytes and round spermatids in mouse. In other studies, male germ cells were reported to contain protein(s) that is able to specifically bind to 3'-untranslated region of mouse P68 helicase (22). Based on its structural characteristics and in vitro function (3) we proposed that GRTH might function as a translational activator to promote protein expression of crucial gene(s) at selective stages of the spermatogenic cycle. It is not known whether the above three distantly related RNA helicases have synergistic, independent, or substitutive roles in the regulation on spermatogenesis. The similarity of these protein sequences with GRTH is only limited to the conserved motifs of the RNA helicase gene family and displayed very low overall similarities (32–35%). The physiological significance and role of GRTH during the spermatogenic cycle remains to be determined.

The distribution and regulatory pattern of GRTH gene expression at the protein level is similar to its mRNA expression in tissues and cells examined (3). The testicular cell-specific and hormonal-dependent usage of translation codons for GRTH protein synthesis add complexity and diversity to regulatory mechanism(s) that may participate during testicular development. The up-regulation of GRTH protein by gonadotropin in the Leydig cells follows closely the down-regulation of receptors, steroidogenic enzymes, and acyl-CoA synthetase (gonadotropin-regulated long chain acyl-CoA synthetase) (4, 23), and its return to control levels is concomitant to its recovery from down-regulation. These changes could be reflective of the existence of a regulated mechanism responsible for recovery of down-regulated transcriptional events through increases in translatability of the reduced relevant messages. The findings presented in this study demonstrate a cell-, stage-, and compartment-specific expression of GRTH protein in testicular cells and provide further evidence for potential roles of GRTH in the control of steroidogenesis and spermatogenesis in the testis. Development of GRTH null mice will establish the physiological function of the protein.


    FOOTNOTES
 
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{ddagger} To whom correspondence should be addressed: Bldg. 49, Rm. 6A-36, 49 Convent Dr., MSC 4510, National Institutes of Health, Bethesda, MD 20892-4510. Tel.: 301-480-8010; E-mail: dufau{at}helix.nih.gov.

1 The abbreviations used are: GRTH, gonadotropin-regulated testicular RNA helicase; hCG, human chorionic gonadotropin; GFP, green fluorescent protein; nt, nucleotide(s); PBK, Bluescript plasmid. Back

2 C. H. Tsai-Morris, Y. Sheng, and M. L. Dufau, unpublished information. Back

3 Q. Jiang, C.-H. Tsai-Morris, and M. L. Dufau, unpublished observations. Back



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Schmid, S. R., and Linder, P. (1992) Mol. Microbiol. 6, 283–291[Medline] [Order article via Infotrieve]
  2. de la Cruz, J., Kressler, D., and Linder, P. (1999) Trends Biochem. Sci. 24, 192–198[CrossRef][Medline] [Order article via Infotrieve]
  3. Tang, P. Z., Tsai-Morris, C. H., and Dufau, M. L. (1999) J. Biol. Chem. 274, 37932–37940[Abstract/Free Full Text]
  4. Dufau, M. L., Tsai-Morris, C., Tang, P., and Khanum, A. (2001) J. Steroid Biochem. Mol. Biol. 76, 187–197[Medline] [Order article via Infotrieve]
  5. Aquilano, D. R., and Dufau, M. L. (1984) Endocrinology 114, 499–510[Abstract]
  6. Bucci, L. R., Brock, W. A., Johnson, T. S., and Meistrich, M. L. (1986) Biol. Reprod. 34, 195–206[Abstract]
  7. Leblond, C. P., and Clermont, Y. (1952) Ann. N. Y. Acad. Sci. 55, 548–573
  8. Gee, S. L., and Conboy, J. G. (1994) Gene 140, 171–177[CrossRef][Medline] [Order article via Infotrieve]
  9. Schmitt, C., von Kobbe, C., Bachi, A., Pante, N., Rodrigues, J. P., Boscheron, C., Rigaut, G., Wilm, M., Seraphin, B., Carmo-Fonseca, M., and Izaurralde, E. (1999) EMBO J. 18, 4332–4347[Abstract/Free Full Text]
  10. Ichihara, I., Kawamura, H., and Pelliniemi, L. J. (1993) Cell Tissue Res. 271, 241–255[Medline] [Order article via Infotrieve]
  11. Descombes, P., and Schibler, U. (1991) Cell 67, 569–579[Medline] [Order article via Infotrieve]
  12. Ossipow, V., Descombes, P., and Schibler, U. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 8219–8223[Abstract/Free Full Text]
  13. O'Donovan, K. J., and Baraban, J. M. (1999) Mol. Cell. Biol. 19, 4711–4718[Abstract/Free Full Text]
  14. Byrd, M. P., Zamora, M., and Lloyd, R. E. (2002) Mol. Cell. Biol. 22, 4499–4511[Abstract/Free Full Text]
  15. Babik, J. M., Adams, E., Tone, Y., Fairchild, P. J., Tone, M., and Waldmann, H. (1999) J. Immunol. 162, 4069–4078[Abstract/Free Full Text]
  16. Vornberger, W., Prins, G., Musto, N. A., and Suarez-Quian, C. A. (1994) Endocrinology 134, 2307–2316[Abstract]
  17. McLachlan, R. I., O'Donnell, L., Meachem, S. J., Stanton, P. G., de Kretser, D. M., Pratis, K., and Robertson, D. M. (2002) Recent Prog. Horm. Res. 57, 149–179[Abstract/Free Full Text]
  18. Tanaka, S. S., Toyooka, Y., Akasu, R., Katoh-Fukui, Y., Nakahara, Y., Suzuki, R., Yokoyama, M., and Noce, T. (2000) Genes Dev. 14, 841–853[Abstract/Free Full Text]
  19. Styhler, S., Nakamura, A., Swan, A., Suter, B., and Lasko, P. (1998) Development 125, 1569–1578[Abstract/Free Full Text]
  20. Leroy, P., Alzari, P., Sassoon, D., Wolgemuth, D., and Fellous, M. (1989) Cell 57, 549–559[Medline] [Order article via Infotrieve]
  21. Lemaire, L., and Heinlein, U. A. (1993) Life Sci. 52, 917–926[CrossRef][Medline] [Order article via Infotrieve]
  22. Sandhu, H., Lemaire, L., and Heinlein, U. A. (1995) Biochem. Biophys. Res. Commun. 214, 632–638[Medline] [Order article via Infotrieve]
  23. Tang, P. Z., Tsai-Morris, C. H., and Dufau, M. L. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 6581–6586[Abstract/Free Full Text]